CRO support for ncats in vitro and in vivo toxicology studies

Ended Awarded Last action

Contract number
HHSN271201700016I
Awardee
Awarding agency
Task orders
11 $12,323,017 obligated

Award facts

Opportunity
Combined order value
  • $12,323,017 Current, with exercised options
  • $14,052,477 Potential, with all options
Last date to order 100% complete
IDV ceiling 31% used
$39,804,016.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Non-clinical safety assessment of covalent BI-TOX to support neuropathic pain indication 75N95022F00001 National Institute on Drug Abuse (NIH) $765,995
Non-clinical safety assessment of drinabant, a cannabinoid receptor (CB-1) antagonist, for acute cannabinoid overdose… 75N95020F00003 National Institute on Drug Abuse (NIH) $751,371
Task order title: non-clinical safety of mitragynine to support its future oral therapy for analgesia indication… 75N95020F00002 National Institute on Drug Abuse (NIH) $2,373,515
Non-clinical safety of PTH-1A, inverse agonist, to support jansen metaphyseal chondrodysplasia (JMC) disease. POP… 75N95020F00001 National Institute on Drug Abuse (NIH) $3,053,804
Non-clinical safety assessment of acoziborole (scyx-7158) to support human african trypanosomiasis (HAT or "sleeping… 75N95019F00091 National Institute on Drug Abuse (NIH) $1,156,165
GLP 28 day toxicity study of act-1 when applied topically to eyes twice daily for 28 days in dogs with a 14 day… 75N95019F00090 National Institute on Drug Abuse (NIH) $547,622
Non-clinical safety assessment of BPN14770 to support pediatric population with fragile x syndrome 75N95018F00005 National Institute on Drug Abuse (NIH) $789,821
IIT research institute:1107221 75N95018F00004 National Institute on Drug Abuse (NIH) $913,178
IIT resch institute:1107221 [18-005715] to perform the study "single PO dose cardiovascular and pulmonary safety… 75N95018F00003 National Institute on Drug Abuse (NIH) $130,093
IIT research institute:1107221 [18-004523] 75N95018F00002 National Institute on Drug Abuse (NIH) $271,489
Task order award for "non-clinical safety assessment of spif to support chronic gvhd indication" to IIT research… HHSN27100001 National Institute on Drug Abuse (NIH) $1,569,964
Show all 11

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Funding Only Action 1 · Parent award CRO support for ncats in vitro and in vivo toxicology studies -$6,500
Original award $6,500

Quick answers

Who was awarded contract HHSN271201700016I?

HHSN271201700016I was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on April 21, 2017.

How much is contract HHSN271201700016I worth?

Orders under HHSN271201700016I have obligated $12,323,017. Their combined potential value, with all options, is $14,052,477. HHSN271201700016I's own ceiling is $39,804,016.

How many orders have been placed under contract HHSN271201700016I?

11 orders have been placed under HHSN271201700016I, the latest on September 23, 2022.

Which agency awarded contract HHSN271201700016I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700016I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201700016I?

HHSN271201700016I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201700016I part of a contract vehicle?

Yes. HHSN271201700016I is part of CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.

Was contract HHSN271201700016I competed?

The extent of competition for HHSN271201700016I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV